Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2107-9.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Marrow / drug effects
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use*
  • Drug Evaluation
  • Hearing / drug effects
  • Humans
  • Kidney / drug effects
  • Lung Neoplasms / drug therapy*
  • Vomiting / chemically induced

Substances

  • Cisplatin